Larynox

Benzydamine Hydrochloride, the active ingredient in Larynox, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oropharyngeal solution for local use. It provides anti‑inflammatory, analgesic and antiseptic effects for sore throat, oral mucositis and other inflammatory conditions of the oropharynx.

GNH USA supplies Larynox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Larynox, a benzydamine‑based NSAID, is used for inflammatory conditions of the upper throat and mouth. - Sore throat: reduces pain, swelling and irritation in acute pharyngitis. - Oral mucositis: alleviates discomfort and inflammation associated with chemotherapy or radiotherapy. - Inflammatory conditions of the oropharynx: provides local anti‑inflammatory and antiseptic action for various non‑infectious throat inflammations.

Larynox is generally well tolerated, but some users may experience local or systemic reactions.

Common Side Effects: - Taste alteration: transient metallic or bitter taste in the mouth. - Mild burning or stinging: sensation at the site of application. - Local irritation: redness or mild discomfort of the oral mucosa. - Nausea: occasional feeling of queasiness after use. - Dry mouth: temporary reduction in salivation.

Serious or Rare Side Effects: - Allergic reactions: rash, itching or urticaria. - Angioedema: swelling of lips, tongue or face requiring immediate medical attention. - Severe mucosal ulceration: persistent lesions in the oral cavity. - Anaphylaxis: rare systemic hypersensitivity reaction. - Persistent dysphagia: difficulty swallowing that does not resolve.

Before using Larynox, consider the following safety measures. - Allergy assessment: avoid if known hypersensitivity to benzydamine or related compounds. - Pregnancy and lactation: consult a healthcare professional as safety data are limited. - Concomitant oral lesions: use with caution in patients with extensive oral ulcerations. - Pediatric use: not recommended for children without medical advice. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Larynox may interact with other agents that affect the oral mucosa or systemic inflammation.

Major Interactions (Avoid): - Concurrent use of other topical NSAIDs in the mouth: may increase local irritation. - Systemic anticoagulants: potential for enhanced bleeding risk if extensive mucosal injury occurs.

Moderate Interactions (Monitor Closely): - Alcohol consumption: may exacerbate mucosal irritation. - Other local anesthetics: could potentiate numbness. - Corticosteroid mouth rinses: monitor for additive anti‑inflammatory effects.